Quantification of specific T and B cells immunological markers in children with chronic and transient ITP-Reference-Cited by-同舟云学术

Quantification of specific T and B cells immunological markers in children with chronic and transient ITP

Published:2017-05-22 Issue:12 Volume:64 Page:e26646
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Levy-Mendelovich Sarina¹²³,Lev Atar¹,Aviner Shraga⁴,Rosenberg Nurit⁵,Kaplinsky Caim²,Sharon Nechama⁶,Miskin Hagit⁷,Dvir Aviya⁵,Kenet Gili³,Schushan Irit Eisen⁸,Somech Raz¹^ORCID

Affiliation:

1. Pediatric Department A and the Immunology Services; “Edmond and Lily Safra” Children's Hospital; Jeffrey Modell Foundation Center; Sheba Medical Center; Tel Hashomer affiliated with Sackler School of Medicine; Tel Aviv University; Tel Aviv Israel

2. Pediatric Hemato-Oncology Department; “Edmond and Lily Safra” Children's Hospital, Sheba Medical Center, Tel Hashomer affiliated to Sackler School of Medicine, Tel Aviv University; Tel Aviv Israel

3. National Hemphilia and Thrombosis Institute, Sheba Medical Center; Tel Hashomer affiliated to Sackler School of Medicine; Tel Aviv University Israel

4. Department of Pediatrics; Barzilai University Medical Center; Ashkelon affiliated to Ben Gurion University; Beer-Sheva Israel

5. Institute of Thrombosis and Hemostasis; Chaim Sheba Medical Center, Tel Hashomer affiliated to Sackler School of Medicine; Tel Aviv University Israel

6. Pediatric Department, Laniado Hospital; Netanya affiliated to Sackler School of Medicine; Tel Aviv University Israel

7. Pediatric Hematoloy Unit; Shaare Zedek Medical Center; Jerusalem affiliated to Hebrew University School of Medicine; Jerusalem Israel

8. Neonatology Department; “Edmond and Lily Safra” Children's Hospital, Sheba Medical Center; Tel Hashomer affiliated to Sackler School of Medicine; Tel Aviv University Israel

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference29 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;Rodeghiero;Blood,2014

2. A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis;Cuker;Blood,2011

3. Immune thrombocytopenic purpura-the changing therapeutic landscape;Bromberg;New Engl J Med,2006

4. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents;O'Leary;Pediatrics,2012

5. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura;Blanchette;Lancet,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome profiling reveals distinct alterations in the B-cell signature and dysregulation of peripheral B-cell subsets in sickle cell anemia patients;Experimental Hematology;2024-09

2. Machine learning models developed and internally validated for predicting chronicity in pediatric immune thrombocytopenia;Journal of Thrombosis and Haemostasis;2023-12

3. Expansion of the immature B lymphocyte compartment in Graves' disease;European Journal of Endocrinology;2023-08

4. Machine Learning Models Developed and Internal Validated for Predicting Chronicity in Chinese Children Immune Thrombocytopenia;2023

5. Blockage of CD72 reduces B cell proliferation in immune thrombocytopenic purpura, involving interleukin 1 and macrophage migration inhibitory factor secretion;Hematology;2022-11-03